高级检索

化学药品标准物质的研制与使用

冯艳春, 裴文莉, 宁保明, 史继峰

冯艳春,裴文莉,宁保明,等. 化学药品标准物质的研制与使用[J]. 中国药科大学学报,2024,55(5):715 − 720. DOI: 10.11665/j.issn.1000-5048.2023122402
引用本文: 冯艳春,裴文莉,宁保明,等. 化学药品标准物质的研制与使用[J]. 中国药科大学学报,2024,55(5):715 − 720. DOI: 10.11665/j.issn.1000-5048.2023122402
FENG Yanchun, PEI Wenli, NING Baoming, et al. Development and application of chemical reference materials[J]. J China Pharm Univ, 2024, 55(5): 715 − 720. DOI: 10.11665/j.issn.1000-5048.2023122402
Citation: FENG Yanchun, PEI Wenli, NING Baoming, et al. Development and application of chemical reference materials[J]. J China Pharm Univ, 2024, 55(5): 715 − 720. DOI: 10.11665/j.issn.1000-5048.2023122402

化学药品标准物质的研制与使用

基金项目: 中国食品药品检定研究院化学药品检定所重点实验室学科建设课题(2024HYZX20)
详细信息
    通讯作者:

    史继峰: Tel:010-67871133 E-mail:shijifeng@kawin.com.cn

  • 中图分类号: R927

Development and application of chemical reference materials

Funds: This study was supported by the Project on Discipline Construction of Key Laboratory of Chemical Drug Control Institute, National Institutes for Food and Drug Control (2024HYZX20)
  • 摘要:

    化学药品标准物质是化学药品研发和质量监控过程中重要的物质基础。本文介绍了化学药品标准物质的定义、分类;详细梳理了制药企业和权威标准物质发放机构对于化学药品标准物质研发、生产、管理和使用的国内外相关法规和指导原则;化学药品标准物质原料常用的制备方法和关键技术以及不同类型化学药品标准物质对于原料选择的技术要求。除此之外,本文还介绍了候选标准物质原料经过化学结构确证、理化性质分析、均匀性评估、稳定性监测、赋值之后成为化学药品标准物质的常规研制流程和数据要求,并对经典的赋值方法——质量平衡法进行了详细的介绍,从而为国内化学药品标准物质的使用者以及新药的开发者提供化学药品标准物质研制、使用和管理相关的技术参考。

    Abstract:

    Chemical reference material (CRM) is an important material basis in the process of chemical drug research and development and quality control. This paper introduces the definition and classification of CRMs; the domestic and international regulations and guidelines for the research and development, production, management and use of CRMs by pharmaceutical companies and authoritative CRM issuing organizations; the common preparation methods and key technologies of CRM raw materials; and the technical requirements for the selection of raw materials for different types of CRMs. In addition, this paper also introduces the routine development process and data requirements for the candidate raw material to become a CRM after chemical structure verification, physical and chemical property analysis, homogeneity assessment, stability monitoring, and assignment. It also introduces the classical assignment method, mass balance method, in detail, to provide users of CRMs and the developers of new drugs with some technical references related to the development, application and management of CRMs in China.

  • [1] National Institutes for Food and Drug Control. Testing Technology for Pharmaceutical Excipients and Packaging Materials (药用辅料和药品包装材料检验技术)[M]. Beijing: China Medical Science Press, 2019: 77-78.
    [2] Tan LY, Cai T, Wang Y. Research progress in quantitative analysis methods for chemical reference substances[J]. Chin J Pharmacov (中国药物警戒), 2023, 20(11): 1209-1216.
    [3] Ning BM, Huang HW, Zhang QM et al. Introduction of WHO general guidelines for the establishment maintenance and distribution of chemical reference substances[J]. Chin J Pharm Anal (药物分析杂志), 2010, 30 (1): 166-172.
    [4] Chen GL, Xu XY, Wang YT. The determination of pharmaceutical reference materials during new drug development and research[J]. Shanghai Measurement Test (上海计量测试), 2002, 29(2): 18-20.
    [5] Chen YF, Xiao XY, Li B. Introduction of quality management of international pharmaceutical reference materials and their implication in China[J]. Chin Pharm Aff (中国药事), 2013, 27(12): 1258-1261.
    [6] Ning BM, Yan J, Zhang QM, et al. Introduction of guideline for establishment of European pharmacopoeia reference standard[J]. Drug Stand China (中国药品标准), 2006, 7(4): 74-79.
    [7] Wang XC, Zhang XY, Li C, et al. USA Chemical reference standard materials’ management overview and analysis[J]. Chin J Vet Drug (中国兽药杂志), 2018, 52(10): 16-21.
    [8] Zhu HJ. Brief introduction of pharmaceutical reference materials[J]. Chem Reagents (化学试剂), 2017, 39(4): 379-384.
    [9] Niu JZ, Ning BM, Zhang QM. Application and study on chemical reference substances[J]. Chin Pharm J (中国药学杂志), 2011, 46(11): 877-880.
    [10] Xie JX, Wang Q, Liu ML, et al. Risk management and countermeasures of collection of raw materials of national pharmaceutical standard[J]. Chin J Pharm (中国医药工业杂志), 2022, 53(12): 1814-1819.
    [11] Chen YF, Sun Y. Discussion on procurement and management of pharmaceutical candidates of reference standard[J]. Chin Pharm Aff (中国药事), 2014, 28(3): 251-254.
    [12] Li Y, Yin LJ, Zhu JJ, et al. Standardized management and use of pharmaceutical standard materials[J]. Chin Pharm (中国药业), 2021, 30(17): 24-27.
    [13] Li X, Hu SG. Discussion on requirement of reference substances in chemical drug development[J]. Chin J Pharm (中国医药工业杂志), 2013, 44(4): 420-423.
    [14] Chen YF, Li XD, Liu ML, et al. Quality management requirements for pharmaceutical reference standards on essential characteristics and production specification[J]. Chin Pharm Aff (中国药事), 2017, 31(2): 134-138.
    [15] Chen YF, Liu ML, Xie JX, et al. On management of pharmaceutical reference standards and quality control for research and production[J]. Chin Pharm Aff (中国药事), 2018, 32(11): 1505-1510.
    [16] Han NN, Zhao FH, Wang L, et al. Comparative study of management mode and development technology on Chinese veterinary pharmaceutical reference standards and domestic or foreign drug reference standards[J]. Chin J Vet Drug (中国兽药杂志), 2022, 56(4): 31-36.
    [17] Li Y, Liu YL, He RL, et al. Establishment of the first national reference standard of polyacrylic resin II[J]. Chin J Pharm Anal (药物分析杂志), 2013, 33(3): 514-516.
计量
  • 文章访问数:  105
  • HTML全文浏览量:  28
  • PDF下载量:  35
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-12-23
  • 刊出日期:  2024-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭